Corcept Therapeutics Incorporated shares owned by State Street Corporation
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by State Street Corporation
from 13F filings
Historical chart of State Street Corporation investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by State Street Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $247M | 3.0M | 83.11 |
| 2025-06-30 | $218M | 3.0M | 73.40 |
| 2025-03-31 | $389M | 3.4M | 114.22 |
| 2024-12-31 | $179M | 3.5M | 50.39 |
| 2024-09-30 | $163M | 3.5M | 46.28 |
| 2024-06-30 | $114M | 3.5M | 32.49 |
| 2024-03-31 | $90M | 3.6M | 25.19 |
| 2023-12-31 | $110M | 3.4M | 32.48 |
| 2023-09-30 | $86M | 3.1M | 27.25 |
| 2023-06-30 | $71M | 3.2M | 22.25 |
| 2023-03-31 | $71M | 3.3M | 21.66 |
| 2022-12-31 | $65M | 3.2M | 20.31 |
| 2022-09-30 | $89M | 3.5M | 25.64 |
| 2022-06-30 | $83M | 3.5M | 23.78 |
| 2022-03-31 | $77M | 3.4M | 22.52 |
| 2021-12-31 | $66M | 3.3M | 19.80 |
| 2021-09-30 | $64M | 3.3M | 19.68 |
| 2021-06-30 | $72M | 3.3M | 22.00 |
| 2021-03-31 | $77M | 3.2M | 23.79 |
| 2020-12-31 | $85M | 3.2M | 26.16 |
| 2020-09-30 | $55M | 3.2M | 17.41 |
| 2020-06-30 | $55M | 3.3M | 16.82 |
| 2020-03-31 | $38M | 3.2M | 11.89 |
| 2019-12-31 | $37M | 3.0M | 12.10 |
| 2019-03-31 | $37M | 3.1M | 11.74 |
| 2018-12-31 | $39M | 2.9M | 13.36 |
| 2018-09-30 | $45M | 3.2M | 14.02 |
| 2018-06-30 | $46M | 2.9M | 15.72 |
| 2018-03-31 | $52M | 3.1M | 16.45 |
| 2017-12-31 | $52M | 2.9M | 18.06 |
| 2017-09-30 | $38M | 1.9M | 19.30 |
| 2017-06-30 | $24M | 2.0M | 11.80 |
| 2017-03-31 | $18M | 1.6M | 10.96 |
| 2016-12-31 | $9.1M | 1.3M | 7.26 |
| 2016-09-30 | $7.8M | 1.2M | 6.50 |
| 2016-06-30 | $6.3M | 1.2M | 5.46 |
| 2016-03-31 | $4.2M | 902k | 4.68 |
| 2015-12-31 | $4.3M | 869k | 4.97 |
| 2015-09-30 | $3.2M | 852k | 3.76 |
| 2015-06-30 | $5.0M | 839k | 6.01 |
| 2015-03-31 | $5.5M | 989k | 5.60 |
| 2014-12-31 | $2.9M | 962k | 3.00 |
| 2014-09-30 | $2.6M | 957k | 2.68 |
| 2014-06-30 | $2.5M | 908k | 2.80 |
| 2014-03-31 | $3.5M | 797k | 4.36 |
| 2013-12-31 | $1.0M | 718k | 1.43 |
| 2013-09-30 | $1.1M | 696k | 1.58 |
| 2013-06-30 | $1.2M | 694k | 1.73 |
| 2013-03-31 | $1.4M | 714k | 2.00 |
| 2012-12-31 | $1.0M | 718k | 1.43 |
| 2012-09-30 | $1.9M | 682k | 2.79 |
| 2012-03-31 | $2.7M | 675k | 3.93 |
| 2011-12-31 | $2.2M | 653k | 3.42 |
| 2011-09-30 | $1.7M | 549k | 3.10 |
| 2011-03-31 | $1.7M | 392k | 4.25 |
| 2010-12-31 | $1.4M | 361k | 3.86 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated